Pfm Health Sciences, LP Biomarin Pharmaceutical Inc Transaction History

Pfm Health Sciences, LP

$1.95 Billion
Q2 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$85.07 - $94.48 $12.6 Million - $14 Million	147,982 Added 42.24%	498,280 $44.1 Million
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $16.5 Million - $19.1 Million	190,732 Added 119.53%	350,298 $30.4 Million
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $13.2 Million - $17.7 Million	-150,835 Reduced 48.59%	159,566 $15.5 Million
Q4 2022 Feb 14, 2023	SELL	$80.93 - $108.63 $65.2 Million - $87.5 Million	-805,548 Reduced 72.19%	310,401 $32.1 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $22.7 Million - $26.8 Million	276,578 Added 32.95%	1,115,949 $94.6 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $8.64 Million - $10.5 Million	120,876 Added 16.82%	839,371 $69.6 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $18.8 Million - $23.5 Million	253,555 Added 54.53%	718,495 $55.4 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $33.3 Million - $42.5 Million	464,940 New	464,940 $41.1 Million
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $23.5 Million - $28.5 Million	-314,499 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $28 Million - $34.8 Million	-385,553 Reduced 55.07%	314,499 $27.6 Million
Q3 2020 Nov 16, 2020	BUY	$71.87 - $131.03 $15.6 Million - $28.4 Million	216,973 Added 44.91%	700,052 $53.3 Million
Q2 2020 Aug 14, 2020	BUY	$79.55 - $124.22 $6.64 Million - $10.4 Million	83,474 Added 20.89%	483,079 $59.6 Million
Q1 2020 May 15, 2020	SELL	$71.37 - $96.85 $11 Million - $14.9 Million	-154,029 Reduced 27.82%	399,605 $33.8 Million
Q4 2019 Feb 14, 2020	SELL	$64.27 - $86.37 $103 Million - $138 Million	-1,595,417 Reduced 74.24%	553,634 $46.8 Million
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $4.7 Million - $5.93 Million	69,663 Added 3.35%	2,149,051 $145 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $167 Million - $195 Million	2,079,388 New	2,079,388 $178 Million

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

Black Rock Inc. New York, NY

22.7M
Shares

$1.6 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$1.34 Billion
0.03% of portfolio
Primecap Management CO Pasadena, CA

18.8M
Shares

$1.33 Billion
1.14% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$983 Million
0.72% of portfolio
Capital Research Global Investors Los Angeles, CA

9.69M
Shares

$684 Million
0.18% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.

Account